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AblAkt kinases are importantmediators of the insulin signal, and someAkt substrates are directly involved in glucose
homeostasis. Recently, Girdin has been described as an Akt substrate that is expressed ubiquitously inmammals.
Cells overexpressing Girdin show an enhanced Akt activity. However, not much is known about Girdin's role in
insulin signaling. We therefore analyzed the role of Girdin in primary human myotubes and found a correlation
between Girdin expression and insulin sensitivity of the muscle biopsy donors, as measured by a
hyperinsulinemic–euglycemic clamp. To understand this ﬁnding on a cellular level, we then investigated the
function of Girdin in C2C12 mouse myoblasts. Girdin knock-down reduced Akt and insulin receptor substrate-
1 phosphorylation. In contrast, stable overexpression of Girdin in C2C12 cells strikingly increased insulin
sensitivity through a massive upregulation of the insulin receptor and enhanced tyrosine phosphorylation of
insulin receptor substrate-1. Furthermore, Akt and c-Abl kinases were constitutively activated. To investigate
medium-term insulin responses we measured glucose incorporation into glycogen. The Girdin overexpressing
cells showed a high basal glycogen synthesis that peaked already at 1 nM insulin. Taken together, we
characterized Girdin as a new and major regulator of the insulin signal in myoblasts and skeletal muscle.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Activation of the insulin receptor (IR) and the subsequent signaling
processes regulate cellular homeostasis and whole body metabolism
[1]. The development of insulin resistance, that is the less efﬁcient
propagation of the insulin signal, is a hallmark of diabetes. Thus, all
signaling processes that affect the efﬁciency of the insulin signal are of
high signiﬁcance. Insulin signaling starts with binding of insulin to its
receptor, leading to receptor auto- and substrate phosphorylation [2].
Along the major axis of signaling the insulin receptor substrate (IRS)
proteins are phosphorylated and bind the phosphatidylinositol-3-
kinase (PI3K) that then generate phosphatidylinositol-3-phosphate
leading to Akt kinase activation and mediating glucose transporter 4
translocation to the cell membrane for glucose uptake into skeletal
muscle [3]. Akt activity is mainly regulated by upstream kinases
phosphorylating T308 (PDK-1) or S473 (mTORC2) and the dephosphor-
ylation of these residues by PP2a and PHLPP, respectively [4]. Via
phosphorylation of the glycogen synthase kinase 3 (GSK3) Akt directly
affects glycogen synthesis and via phosphorylation of AS160 it activates
glucose transporter 4 translocation. Impairment of this signalingTübingen, Germany. Tel.: +49
e (R. Lammers).
ights reserved.cascade plays a major role in the development of insulin resistance
and diabetes mellitus [5].
Recently, Girdin, also namedAkt phosphorylation enhancer (APE) or
Gα-interacting vesicle-associated protein (GIV), was identiﬁed as an
Akt or Gα binding protein in yeast two hybrid screens [6–8] or by
computer homology search for Hook related proteins (HkRP1) [9]. So
far, the main function ascribed to Girdin is to enhance and prolong the
Akt kinase activity although the mechanism is still unclear. Two
different signaling processes were proposed to be employed by Girdin
[10,11]: (i) Girdin was identiﬁed as a non-receptor guanine nucleotide
exchange factor for Gαi proteins. Through binding and activation of G
proteins, Girdin induces the release of the Gβγ subunit which in turn
binds and activates p110γ–PI3K. (ii) It was shown that Girdin interacts
with activated receptor and non-receptor tyrosine kinases and binds
and activates the p85α subunit of PI3K. Girdin is tyrosine phosphorylat-
ed at the carboxy-terminus and may stabilize the receptor tyrosine
kinase–PI3K complex and amplify the signaling. Ghosh and colleagues
also showed that in Hela cells which overexpress Girdin, the epidermal
growth factor receptor (EGFR) had an elevated tyrosine phosphoryla-
tion but a decreased internalization after ligand binding compared to
control cells [12].
Although Girdin was initially characterized by enhancing the activi-
ty of Akt upon overexpression, a role in insulin signaling or insulin
sensitive tissues has not been clariﬁed. To investigate the role of Girdin
for insulin signaling we tested primary myotubes and observed a
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muscle biopsy donors. We then set out to identify the signaling
processes behind this ﬁnding and turned to C2C12 myoblast cells.
Girdin knock-down decreased insulin sensitivity in C2C12 myo-
blasts but stable overexpression of Girdin led to a massive increase
in insulin sensitivity. Our data indicate that Girdin is a critical reg-
ulator of insulin sensitivity in the skeletal muscle cell line C2C12
and human muscle.
2. Material and methods
2.1. Ethics statement
The study adhered to the Declaration of Helsinki, and was approved
by the Ethics Committee of the Medical Faculty of the Eberhard Karls
University Tübingen. All participants gave their written consent to the
study.
2.2. Materials
Oligonucleotides were synthesized by Metabion. Commercial
antibodies: α-phospho-Akt Thr308 (#9275), α-phospho-GSKα/β
Ser21/9 (#9331), α-phospho-Erk1/2 Thr202/Tyr204 (#9106), α-
Erk1/2 (#9102), α-phospho-p70/p85 S6K Thr389 (#9206) and
p70/p85 S6K (#9202) were purchased from Cell Signaling; α-
phospho-IRS-1 Tyr989, α-GSKα/β (#7291/0011-Α) and α-c-Abl
(#23/24–11) were obtained from Santa Cruz; α-Akt was obtained
from BD-Transduction (#610861); α-IRS-1 (#06-248) and α-
phosphotyrosine (4G10) were obtained from Millipore; and α-
phospho-IR Tyr972 was obtained from Assay Designs. The antibody
against Girdin was raised against the coiled coil domain (aa 783–988);
IR- and CrkII antibodies against a carboxy-terminal peptide and GST-
IRS-1 antibody against a GST-fusion protein containing the carboxy-
terminal 300 amino acids.
2.3. Cell culture and transfection
C2C12 murine myoblasts (ATCC, CRL-1772) were cultivated in
DMEM (Lonza) containing 4.5 g/L glucose, 2 mM glutamine and
10% FCS (Thermo Scientiﬁc). Cells were plated and grown until
approximately 80–90% conﬂuence, serum starved (DMEM 0.5%
FCS) overnight and stimulated for 15 min with different concentra-
tions of insulin (Eli Lilly). STI-571 experiments were performed by
pretreating the cells with 50 μM STI-571 (Cayman) for 24 h or
48 h. For glycogen synthesis and receptor internalization assay
cells were seeded at a density of 1–2 × 105 cells/6-well and cultivat-
ed for 24 h followed by individual protocols (see below). Primary
human skeletal muscle cells were obtained from needle biopsies of
the vastus lateralis muscle of thirty-two mostly young healthy
volunteers. Cells were grown as described [13]. Measurement of
gene expression was done in ﬁrst-pass cells after growth to 80–90%
conﬂuence and ﬁve days of differentiation to myotubes [14]. The
differentiation media contained 2% fetal calf serum and 1 mg/L
glucose.
Human Girdin cDNA was cloned into the expression vector pRK
(Clontech) and cotransfected with the pSV2neo vector into C2C12
cells using a calcium phosphate precipitation method adapted from
Chen and Okayama [15]. SiRNA transfection with DharmaFECT was
performed according to the manufacturer's instructions (Dharmacon).
2.4. Cell lysis and Western blot analysis
Cells were washed in PBS and lysed in lysis buffer as described
[16]. After protein measurement, SDS loading buffer [3% (w/v) SDS,
3% (v/v) β-mercaptoethanol, 10 mM EDTA (pH 8), 20% (v/v)
glycerol, 0.05% (w/v) bromphenol blue] was added and sampleswere boiled for 5 min at 95 °C. Proteins were separated by SDS-
polyacrylamide gel electrophoresis (PAGE) and transferred to
nitrocellulose ﬁlter. The membranes were blocked for minimum
1 h in Net-G [150 mM NaCl, 5 mM EDTA (pH 8), 50 mM Tris–HCl
(pH 7.5), 0.05% (v/v) Triton X-100, 0.25% (w/v) gelatine] and
incubated with primary antibody overnight at 4 °C. Proteins were
detected by horseradish peroxidase conjugated secondary antibody
and using an ECL reagent (Thermo Scientiﬁc). For quantiﬁcation by
densitometric scanning we used ImageJ software (1.46r).2.5. Glycogen synthesis and IR internalization assay
Glycogen synthesis in C2C12 cells was done as described [17]. To
determine IR internalization, C2C12 cells were incubated with
0.03 μCi 125-I-Insulin (Perkin Elmer) at 4 °C for 1 h in HEPES buff-
ered saline, washed three times with cold HEPES buffer and incubat-
ed for 10 and 30 min at 37 °C. Cells were then placed on ice, washed
two times with acetic acid (0.2 M) and the acid washes collected.
Afterwards, cells were lysed with 30% (w/v) NaOH and the radioac-
tivity of acid washes and lysates was determined by gamma
counting. Receptor internalization was expressed as percentage of
total insulin (bound and internalized) at time point zero.2.6. RNA isolation, RT-PCR and real-time quantitative PCR analysis
Cells were washed once with PBS, lysed with RLT buffer and
homogenized using the QIAshredder (Qiagen) according to the
manufacturer's instructions. Reverse transcription of total RNA (1 μg)
was performed in a volume of 20 μl using random hexamers with the
First Strand cDNA Synthesis Kit for RT-PCR (Roche). Aliquots of 2 μl of
the reverse transcription reactions were used for quantitative PCR
with the Roche LightCycler 1.5 with SYBR® Green. The following
primers were used: IR sense: TCTGAAATTCACAAGATGGAAGAA and
antisense: CCGAATGAAAGAAAATTTAAGCA. The quantitative PCR was
performed in triplicate in a total volume of 20 μl containing 2 μl
FastStart DNA-Master SYBR Green I (Roche), 4 mMMgCl2, and primers
at a concentration of 1 μM. After denaturing at 95 °C for 10 min,
ampliﬁcation was performed by denaturing at 95 °C for 15 s, annealing
at 60 °C for 10 s, and elongation at 72 °C for 6 s. The number of cycles
was 50. The mRNA content is given in relative arbitrary units.
For qPCR analysis of Girdin expression in primary human skeletal
muscle myotubes, RNA was extracted and transcribed as mentioned
before. Then, qPCR was performed in duplicate with ﬂuorescence-
labeled probes from the Roche Universal Probe Library on a Roche
LightCycler 480 according to the manufacturer's instruction. The
following primers were used: Girdin sense: CAAAAGGCTGCAACAA
GAGA and antisense: CTGCTTTCTCTCGAAGTGCAT and RPS13 sense:
CCCCACTTGGTTGAAGTTGA and antisense: ACACCATGTGAATCTCT
CAGGA. These quantitative mRNA data were normalized to the
housekeeping gene RPS13 using the ΔCt method.2.7. Statistical analysis
Statistics were done by analysis of the standard deviation, follow-
ed by Student's t tests. For the statistical analysis of the human data,
all variables with non-normal distribution were loge-transformed
before linear regression analysis. The least-squares method was
used for a multiple linear regression analysis. In the regression
model, insulin sensitivity was chosen as outcome variable, Girdin
mRNA expression as independent variable, and gender, age, and
BMI as possible confounding variables. The signiﬁcance threshold
was set to p b 0.05. The statistical software package JMP 8.0 (SAS
Institute) was used.
Fig. 1. Girdin expression correlates with insulin sensitivity. Analysis of mRNA expression
ofGirdin inprimary humanmyotubeswasmeasuredby real time quantitative PCR. Insulin
sensitivity of participants of the study (n = 32; male 20/female 12) was assessed by a
hyperinsulinemic–euglycemic clamp and adjusted to gender, age (median = 25 y) and
BMI (median = 22.88 kg/m2). All parameters were loge-transformed before linear
regression analysis (r = 0.369; p = 0.0378).
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3.1. Girdin — a parameter for insulin sensitivity in humans
Since Girdin was identiﬁed as a protein enhancing Akt activity and
Akt is a crucial enzyme of the insulin signaling cascade, we investigated
the relevance of Girdin expression for insulin sensitivity in primary
human myotubes. To this end, we performed a hyperinsulinemic–Fig. 2. Girdin knock-down decreases insulin sensitivity in C2C12 cells. (A) C2C12 cells were tran
the cells were stimulated for 15 min with the indicated concentrations of insulin. The cells wer
with protein- and phospho-speciﬁc (p) antibodies as indicated. The antibody detecting IRS-1w
relative arbitrary units; *p b 0.05; **p b 0.005.euglycemic clamp in mostly young healthy volunteers according to
the method described by Stefan et al. [13]. Additionally, the vastus
lateralis muscle of the participants was biopsied. The primary
human skeletal muscle cells obtained from the biopsies were
grown and differentiated into myotubes. Girdin expression was
measured by quantitative PCR and normalized to the housekeeping
gene RPS13. Fig. 1 shows the association of Girdin expression with
the participants' insulin sensitivity adjusted for gender, age and
BMI. Increased insulin sensitivity correlated with an increased
expression of Girdin in human skeletal muscle. These data suggest
that Girdin expression is an important parameter of insulin sensitiv-
ity in skeletal muscle cells.
3.2. Girdin knock-down decreases insulin sensitivity in C2C12 cells
To better understand howGirdinmay improve insulin sensitivitywe
used C2C12 myoblasts to study consequences of changes in Girdin
expression for insulin signaling. To verify the importance of Girdin in
these cells we ﬁrst knocked down endogenous Girdin by transfecting
cells with Girdin speciﬁc siRNA. Western blot analysis of the lysates of
transfected cells indicated a reduction of Girdin protein by 60%whereas
the control siRNA transfected cells showed no Girdin protein decrease
(Fig. 2). Analysis of the IRS-1 protein revealed that a decrease in Girdin
expression also led to a reduction in IRS-1 protein, and upon insulin
stimulation tyrosine phosphorylationwas reduced aswell. Consequent-
ly, Akt phosphorylation at T308 was reduced, although the Akt protein
level was not affected. The reduced Akt phosphorylation reﬂected the
Akt kinase activity, also leading to a diminished phosphorylation of
GSK3α at S21 compared to control cells. Looking at the IR as a possible
cause for the reduced IRS-1 phosphorylation, we did not ﬁnd an effect
of siRNA treatment on IR expression or phosphorylation (Fig. S1). Girdin
was not only important for members of the PI3K-pathway, but also thesfectedwith control or mouse Girdin siRNA or used untransfected. After serum starvation
e then lysed and proteins were separated by SDS-PAGE and analyzed byWestern blotting
as fromMillipore. (B) Densitometric scans of theWestern blot results shown in (A). RAU—
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stimulated phosphorylation of Erk1 was almost abolished in Girdin-
siRNA treated cells compared to control siRNA. Phosphorylation ofFig. 3. Girdin overexpression in C2C12 cells causes manifold changes in protein level and phos
were serum starved and stimulated for 15 min with the indicated concentrations of insulin. C
by SDS-PAGE and Western blotting. (B) Densitometric scans of the Girdin protein and IRS-1 p
PCR. RAU — relative arbitrary units; G — Girdin; *p b 0.05; **p b 0.005.Erk2 and its protein level were also reduced. Taken together, Girdin
expression is an important regulatory mechanism for cellular signaling
processes in C2C12 cells.phorylation status. (A) Parental C2C12 cells and C2C12 cells stably overexpressing Girdin
ells were lysed and the phosphorylation (p) and protein pattern of the lysates analyzed
hosphorylation shown in part (A). (C) mRNA analysis of the IR by real time quantitative
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To investigate the inﬂuence of a permanent increase in Girdin
protein, C2C12 myoblasts were stably transfected with full length
Girdin. As shown in Fig. 3A/B, the approximately fourfold increase in
Girdin protein in both cell lines, as determined by densitometric
scanning, led to a massive change in quantity and phosphorylation of
the IR, here detected as phosphorylation at Y972. Of note, the tyrosine
phosphorylation was already apparent in the absence of insulin, as is
seen frequently when cells express a high amount of a receptor tyrosine
kinase. The level of IR in parental C2C12 cells was too low to be detected
under the conditions used. To get an idea for the reason of the increased
IR expression we isolated RNA from parental and overexpressing cellsFig. 4. (A) Effects on IR distal signaling byGirdin overexpression in C2C12 cells. Cellswere treate
proteins. (B) Densitometric scans of Akt and GSK3α phosphorylation shown in part (A). (C) Re
were left untreated or transfected with control or speciﬁc siRNA, stimulated as indicated and a
results shown in part (C). RAU — relative arbitrary units; G — Girdin; *p b 0.05; **p b 0.005.and performed real time quantitative PCR (Fig. 3C). We found an
approximately threefold higher amount of IR speciﬁc mRNA in Girdin
overexpressing cells. However, this would only in part explain the
higher amount of IR protein found in these cells (see below).
We next looked at the phosphorylation of Y989 of the IRS-1 protein
that was also remarkably increased in Girdin overexpressing cells with-
out changes in IRS-1 protein levels (Fig. 3A/B). We then turned to ana-
lyze IR distal signaling and started with the Akt kinase that is a central
mediator of cellular insulin effects. Activation of the Akt kinase, deter-
mined by its phosphorylation at T308, became insulin-independent
upon Girdin overexpression (Fig. 4). As a loading control, another
aliquot of the same lysatewas blottedwith an antibody directed against
the Akt protein. Akt activation was conﬁrmed by the ﬁnding that thed as described in Fig. 2A and analyzedwith antibodies directed against phosphopeptides or
versal of Girdin overexpression by transfection with siRNA speciﬁc for human Girdin. Cells
liquots of the cell lysates analyzed as before. (D) Densitometric scans of the Western blot
Fig. 5.Overexpression of Girdin in C2C12 cells increases glycogen synthesis. 14-C-glucose
incorporation into glycogen was carried out in C2C12 wild type (ﬁlled circle) and Girdin
overexpressing cells (circle: Girdin overexpressing clone 1/triangle:Girdin overexpressing
clone 2) and measured by liquid scintillation counting. Protein concentrations for each
sample were determined and results are presented as counts per minutes (cpm) per mg
of protein plotted against the insulin concentration. *p b 0.05; **p b 0.005.
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in overexpressing cells. Strikingly, the GSK3α exhibited a lower appar-
ent molecular weight in Girdin overexpressing cells. Two forms of
GSK3α with molecular weights of 53 and 51 kD have been described
by Nikoulina et al. [18] and may arise from different posttranslational
processing. By contrast, GSK3β phosphorylation did not changewith in-
sulin stimulation but expression was slightly reduced.
When testing insulin signaling pathways aside from the PI3K-
pathway,weﬁrst looked at Erk activity. Expression and insulin stimulat-
ed phosphorylationwere reduced for Erk1,whereas for Erk2 the protein
level was unchanged, but Girdin overexpression led to a reduced basal
phosphorylation and a stronger response to insulin (Fig. 4A). Finally,
phosphorylation at T389 of the kinase of the ribosomal protein S6
(p70-S6K) reﬂects activity of the mTOR kinase, another important
insulin activated kinase regulating transcription, translation and
signaling events. It was strongly reduced whereas protein amount and
phosphorylation of the p85 isoform were enhanced. To check for
physiological consequences of the S6K isoform change, we looked at
IRS-1 degradation that correlates with phosphorylation of IRS-1 at
S636 by S6K. We found that compared to parental cells Girdin
overexpression enhanced IRS-1 degradation after insulin stimulation
(Fig. S2). This indicates that the p85 isoform can act as potent as the
p70 isoform of the S6K. On the other hand, IRS-1 degradation was not
as strong as in IR overexpressing C2C12 cells, indicating that additional
mechanisms are involved. These complex ﬁndings indicate that Girdin
overexpression has many consequences for IR proximal and distal
signaling events in C2C12 cells.
3.4. Downregulation of overexpressed human Girdin reverses the effects on
insulin signaling
To warrant that the in part drastic changes in C2C12 cell physiology
are really due to the increased level of Girdin protein we transfected the
cells with an siRNA speciﬁc for human Girdin and investigated whether
this would reverse the changes. As shown in Fig. 4C/D, 48 h after
transfection the Girdin protein level was reduced, and in parallel,
tyrosine phosphorylation of IRS-1 and the IR was lower as well. In
addition, the expression of the IR was decreased. For IR distal signaling,
activation of theAkt kinasewas tested and found to be reducedwhereas
expression of the proteinwasunchanged.We conclude that the changes
observed in C2C12 cells overexpressing Girdin are reversible and thus
represent true Girdin dependent effects.
3.5. Overexpression of Girdin in C2C12 cells increases glycogen synthesis
To investigate the consequences of activation of the PI3K-pathway
for midterm insulin signaling, we turned to analysis of glycogen
synthesis. This assay is a readout for glucose uptake and incorporation
into glycogen in response to insulin. Compared to parental C2C12
cells, Girdin overexpressing cells showed signiﬁcantly higher glycogen
synthesis even without stimulation (Fig. 5). In addition, the insulin
sensitivity was elevated with glycogen synthesis peaking at 1 nM.
However, the increased sensitivity was lost at 3 nM and even decreased
at higher, not physiological concentrations of insulin. Thus, Girdin
overexpression is improving glycogen synthesis and insulin sensitivity
of muscle cells at low insulin concentrations.
3.6. Girdin overexpression reduces insulin receptor internalization
Girdin overexpression led to an increased expression of endogenous
IR that was in part based upon a higher transcription (Fig. 3). Since
Ghosh et al. [12] found a reduced internalization of EGFR in Girdin
overexpressing Hela cells, we investigated IR internalization in C2C12
cells. Measurements of binding and incorporation of 125-I-labeled
insulin were done in Girdin overexpressing cells and in C2C12 cells
which stably overexpress a similar amount of human IR (Fig. 6). Ourdata reveal that Girdin overexpression led to a signiﬁcantly reduced
receptor internalization that is only half of that of the control cells. We
conclude that similar to what has been described for the EGFR, the IR
internalization is also affected by Girdin.
3.7. Girdin overexpression leads to constitutively active Abl kinase
Since Girdin overexpression in C2C12 cells upregulated the IR we
explored the insulin-induced changes in the general tyrosine phosphor-
ylation pattern of these cells. Parental and overexpressing cells were
treated with the indicated amounts of insulin and cell lysates probed
for phosphotyrosine (Fig. 7A). A protein of about 120 kD was strongly
phosphorylated in parental but not in Girdin overexpressing cells. By
immunoprecipitation, it was identiﬁed as the FAK kinase (data not
shown) that is well known to be affected by the IR in a cell line
dependent manner [19]. By contrast, the IR at 97 kD was strongly and
in part insulin independently phosphorylated, as was the case for IRS-
1 at approximately 180 kD. In addition, proteins at about 140, 66 and
around 50 kD were stronger phosphorylated. The latter two proteins
were identiﬁed to bemembers of the Shc family of proteins by immuno-
precipitation experiments (data not shown) whereas the 140 kD
protein was identiﬁed as the Abl kinase (Fig. 7B). Of note, Abl protein
expression was similar for parental and transfected cells but it was con-
stitutively phosphorylated and thus active only in transfected cells.
Since the Abl kinase has been implicated inmediating aspects of insulin
signaling, we investigated its contribution in this cell line by treatment
with the Abl-inhibitor STI-571/gleevec. First, we conﬁrmed the kinase
inhibition by immunoprecipitating the Abl substrate CrkII from STI-
571 treated and untreated cells. As shown in Fig. 7C, CrkII phosphoryla-
tion was strongly reduced under these conditions. We then analyzed
lysates from cells treated for 24 or 48 h and found that phosphotyrosine
in general was reduced but phosphotyrosine of the 140 kD protein was
abolished (Fig. 7D). Further, the IR running at 97 kDwas less expressed
and contained less phosphotyrosine. The slightly lower apparent
molecularweight also indicates loss of other posttranslationalmodiﬁca-
tions. IR downstream signaling was affected at the level of Akt that was
better insulin stimulable after 24 h and less activated after 48 h
although the protein level was not changed (Fig. 7D/E). Little effects
were seen for Erk- or p85-S6K-activation. By contrast, the residual
T389-phosphorylation of the p70-S6K isoform was abolished by STI-
571 treatment, as had been shown earlier by Parmar et al. [20]. To test
a direct effect of Girdin on c-Abl phosphorylation, we treated the cells
with siRNA against human Girdin and looked at Abl-phosphorylation
in total cell lysates (Fig. S3). The phosphorylated protein at 140 kD,
Fig. 6. Girdin overexpression reduces insulin receptor internalization. (A) An IR internalization assay was performed using C2C12 cells which overexpress human IR or Girdin. (B) In par-
allel, cells were lysed and lysateswere separated by SDS-PAGE and immunoblotted for Girdin, tubulin, IR and Akt. IR expressionwas evaluated by scanning densitometry and expressed as
the relation of IR to Akt protein. RAU — relative arbitrary units; *p b 0.05; **p b 0.005.
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we looked at the consequences of inhibition of c-Abl for IR internaliza-
tion and glycogen synthesis (Fig. S4). After treatmentwith the inhibitor,
IR was internalized more efﬁciently whereas glycogen synthesis
decreased to about half. We conclude that activity of the Abl kinase is
an important feature in Girdin overexpressing cells that contributes to
the complex phenotype.
4. Discussion
Akt is a regulator of the actin cytoskeleton organization, and this
activity is mediated via its substrate Girdin [7]. Especially in cancer
cells Girdin is expressed at a higher level, is required for migration and
may be involved in cancer progression and metastasis [21]. Besides
the activation of the Akt kinase and its downstream signaling, not
much is known about Girdin's role in insulin signaling. In this work
we identiﬁed a correlation of Girdin expression in myotubes and
whole body insulin sensitivity and subsequently investigated the
function of Girdin in a myoblast cell line.
4.1. Girdin expression regulates insulin sensitivity in myoblasts
Knock-down of Girdin expression in C2C12 cells led to decreased
insulin sensitivity. Cells displayed a slightly reduced IRS-1 protein
level and strongly reduced IRS-1 tyrosine phosphorylation after insulin
treatment. Furthermore, these cells showed an impaired activation of
Akt, as was also reported in similar knock-down experiments using
HepG2orHela cells [6,22]. In contrast, C2C12 cells stably overexpressing
Girdin showed an increased insulin signaling. The IR was strongly
upregulated and constitutively phosphorylated. This constitutive
activity may be a consequence of its enhanced expression and is also
found in C2C12 cells overexpressing a similar amount of the human IR
(C2C12-IR cells in Fig. 6B; data not shown). Insulin stimulation led to
an enhanced tyrosine phosphorylation of IRS-1 but there was no IRS-1
phosphorylation in the absence of insulin. Nevertheless, the cells
exhibited a constitutively active Akt kinase in the absence of insulin,
as demonstrated by phosphorylation of the downstream substrate
GSK3. This important effect was also reported upon transient
overexpression of Girdin in HepG2 and COS7 cells [6] and may in part
be based on the guanine nucleotide exchange factor activity of Girdin
that frees Gβγ subunits and activates p110β of the PI3K [10,23]. Lin
et al. [11] reported that Girdin can be tyrosine phosphorylated anddirectly binds to the p85 subunit of the PI3K as well as the EGFR and
in this way enhances the signaling. Unfortunately, we were not able to
show tyrosine phosphorylation of Girdin or any interaction between
Girdin and IR or p85 (PI3K) either in C2C12-Girdin or transiently
overexpressing cells (data not shown). Of note, the C2C12-IR cells
displayed a similar pattern of IR and IRS-1 phosphorylation but Akt
was only active after insulin stimulation (not shown).
An important negative regulator of the PI3K-pathway, p70-S6K,
differed betweenwild type and Girdin expressing cells. The phosphory-
lation of p70-S6K was reduced and the p85-S6K isoform was
upregulated and phosphorylated in C2C12-Girdin cells. Initially, the
p85 isoform was thought to be nuclear and involved in cell division
[24,25]. However, later reports found both isoforms in the nucleus and
the cytoplasm [26,27], or the p85 isoform only in the cytoplasm [28].
Although the activation mechanism differs between the isoforms, as
only p85 can be phosphorylated independent of mTOR and the PI3K-
pathway, a functional difference is not clear [27,29]. But since IRS-1
degradation after insulin stimulation was rather enhanced in C2C12-
Girdin compared to parental cells, the p85-S6K is at least as potent in
phosphorylating IRS-1 as the p70 isoform.4.2. Girdin overexpression and increased insulin receptor expression
C2C12-Girdin cells showed an upregulated IR expression that
contributed to the enhanced downstream signaling after insulin
stimulation. As possible reasons for IR overexpression we found an
approximately threefold rise of the IR mRNA level and a reduced IR
internalization rate. Ghosh et al. [12] proposed a direct interaction
of the EGFR with Girdin and a direct and negative effect of Girdin
on internalization in Hela cells. Although intracellular trafﬁcking of
EGFR and IR is only initially similar [30] this ﬁnding points to a
general effect of Girdin on receptor internalization. Our experiment
showing that the Abl-inhibitor STI-571 improves internalization in-
dicates a causal role of c-Abl in this process. Balaji et al. [31] also
recently described c-Abl together with Rin1 and Rab5 as important
regulators for EGFR internalization. However, we did not ﬁnd a
difference for expression of Rab5 and could not detect Rin1 in
C2C12 with the antibodies available.
In addition and not yet investigated, the 3′-untranslated region of
the IR mRNA could differ from that in parental C2C12 cells. This would
affect mRNA stability and translation efﬁciency, as described by Lee
Fig. 7.Girdin overexpression leads to constitutive phosphorylation of c-Abl. (A) Parental C2C12 andGirdin overexpressing cellswere starved and treatedwith the indicated concentrations
of insulin. The cells were lysed and lysates were separated by SDS-PAGE and immunoblotted for phosphotyrosine (PY). (B) Cell lysates were also used for immunoprecipitation of c-Abl
with a speciﬁc antibody. After separation by SDS-PAGE and immunoblotting for phosphotyrosine, themembranewas stripped and reblottedwith c-Abl antibody. (C)Wild type and Girdin
overexpressing C2C12 cells were pretreated with STI-571 (50 μM) for 4 h and lysed. CrkII was immunoprecipitated with a speciﬁc antibody and the samples analyzed by SDS-PAGE and
Western blotting with the indicated antibodies. (D) Pretreatment of C2C12 cells which stably overexpress Girdin with STI-571 (50 μM) or DMSO for 24 h or 48 h. The cells were starved
overnight, stimulated with insulin, lysed and proteins analyzed by SDS-PAGE andWestern blotting with speciﬁc antibodies (right panel). (E) Densitometric scan of the Akt phosphoryla-
tion shown in part (D). wcl —whole cell lysate; RAU— relative arbitrary units; **p b 0.005.
2810 A. Hartung et al. / Biochimica et Biophysica Acta 1833 (2013) 2803–2811andGorospe [32]. Since C2C12-Girdin cells overexpress the endogenous
IR, they provide a unique tool to further dissect these regulatory events.
4.3. Girdin stimulates the metabolic pathway by activating c-Abl in C2C12
cells
Our data show that c-Abl was constitutively active in Girdin
overexpressing cells, and inhibition of c-Abl reduced IR expression
and internalization, Akt activation and glycogen synthesis. The role
of c-Abl for the insulin signal was previously investigated by Frasca
et al. [33]. Here, treatment with the inhibitor STI-571 also attenuatedAkt activation and glycogen synthesis but enhanced Erk activation in
different cell types. Frasca and colleagues concluded that c-Abl
signaling is important for restraining the mitogenic and enhancing
the metabolic effects of insulin. These ﬁndings suggest that Girdin
expression regulates insulin signaling also by shifting the cellular
homeostasis from mitogenic to metabolic signals. It would therefore
be of high interest to see whether in tumor derived cell lines with a
higher metastatic potential and expressing an elevated amount of
Girdin c-Abl activity is affected.
Overall, an increased expression of Girdin led to a plethora of
changes in C2C12 cells. These are in part due to higher IR expression
2811A. Hartung et al. / Biochimica et Biophysica Acta 1833 (2013) 2803–2811and activation of the Abl-kinase. In addition, we found changes in
caveolin-1 expression and miRNA pattern (data not shown) that may
also contribute to insulin independent signaling events.
In conclusion, we have provided evidence that regulation of Girdin
expression may be an important parameter of insulin sensitivity in
humans. These ﬁndings encourage further investigations on the
role of Girdin in other insulin sensitive tissues and in the develop-
ment of insulin resistance and diabetes mellitus.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2013.07.012.
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